和邦生物 (603077.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(和邦生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,343,848,975.121,696,145,128.982,394,468,174.842,545,623,215.113,014,294,876.864,392,893,439.353,086,136,455.48
 营业收入(元) 2,343,848,975.121,696,145,128.982,394,468,174.842,545,623,215.113,014,294,876.864,392,893,439.353,086,136,455.48
二、营业总成本(元) 1,892,092,060.671,451,528,331.841,917,401,447.522,050,592,154.362,130,287,988.292,523,355,113.741,850,614,881.23
 营业成本(元) 1,761,637,302.021,355,437,250.931,769,492,414.831,751,017,134.861,838,218,108.542,245,269,658.211,616,810,468.35
 研发费用(元) 10,534,511.669,000,163.219,108,322.9343,485,504.497,499,887.069,282,289.747,666,274.21
 营业税金及附加(元) 14,248,472.5515,241,462.4913,891,280.6520,628,351.2524,438,316.1246,089,093.7622,867,886.64
 销售费用(元) 13,779,675.1113,426,692.0613,859,454.2415,059,125.3916,509,784.038,918,183.1111,995,668.84
 管理费用(元) 94,960,038.5067,339,723.95106,161,061.05222,277,109.00234,343,251.56204,895,882.24183,452,506.13
 财务费用(元) -3,067,939.17-8,916,960.804,888,913.82-1,875,070.639,278,640.988,900,006.687,822,077.06
  其中:利息费用(元) 14,944,868.7212,854,083.8414,275,437.525,476,815.3615,618,026.2115,481,780.0914,857,938.51
  其中:利息收入(元) 15,860,155.9316,914,555.2410,789,441.257,619,887.407,017,225.264,427,987.993,623,533.93
 信用减值损失(元) -10,038,635.62-2,543,860.85-9,040,151.947,311,275.416,847,853.97-6,663,714.79-20,251,493.43
三、其他经营收益
 加:投资收益(元) 3,720,136.2435,973,360.286,412,117.154,497,832.344,433,366.019,363,131.443,536,799.42
  其中:对联营企业和合营企业的投资收益(元) 5,409,827.8936,023,160.363,884,758.151,697,227.604,647,969.438,143,788.225,180,587.76
 资产处置收益(元) 884,645.931,398.073,091.77115,068.4937,167,202.14-170,009.82-9,646.65
 其他收益(元) 6,347,868.462,677,850.332,764,429.7413,535,374.022,974,526.563,924,237.1911,275,777.77
四、营业利润(元) 481,053,407.28252,343,067.15477,206,214.04439,662,363.32935,429,837.251,875,991,969.631,230,073,011.36
 加:营业外收入(元) 6.8625.649.2444,262.571,219.3410,628.182,253.63
 减:营业外支出(元) 50,417.1191,059.79622,403.93159,423.9626,642.4621,281.262,446,054.02
五、利润总额(元) 481,002,997.03252,252,033.00476,583,819.35439,547,201.93935,404,414.131,875,981,316.551,227,629,210.97
 减:所得税费用(元) 70,069,459.0230,570,761.7995,123,195.4563,676,258.60141,790,831.02280,353,207.37182,502,911.84
六、净利润(元) 410,933,538.01221,681,271.21381,460,623.90375,870,943.33793,613,583.111,595,628,109.181,045,126,299.13
(一)按经营持续性分类
  持续经营净利润(元) 410,933,538.01221,681,271.21381,460,623.90375,870,943.33793,613,583.111,595,628,109.181,045,126,299.13
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 402,512,640.68219,970,533.01396,561,190.75379,307,140.80792,866,788.431,591,909,536.921,042,725,403.09
  少数股东损益(元) 8,420,897.331,710,738.20-15,100,566.85-3,436,197.47746,794.683,718,572.262,400,896.04
 扣除非经常性损益后的净利润(元) 397,621,034.56196,466,371.78396,418,118.88368,811,900.57755,114,927.671,590,605,977.611,036,942,438.83
七、每股收益
 一、基本每股收益(元) 0.050.030.050.040.090.180.12
 二、稀释每股收益(元) 0.050.030.050.040.090.180.12
八、其他综合收益(元) -14,136,424.8625,306,987.30-11,232,306.62-9,883,874.9427,863,545.3424,634,568.49647,492.95
 归属于母公司股东的其他综合收益(元) -13,233,409.0417,121,462.47-9,740,716.80-8,002,685.1320,405,719.5718,013,720.52918,984.54
 归属于少数股东的其他综合收益(元) -903,015.828,185,524.83-1,491,589.82-1,881,189.817,457,825.776,620,847.97-271,491.59
九、综合收益总额(元) 396,797,113.15246,988,258.51370,228,317.28365,987,068.39821,477,128.451,620,262,677.671,045,773,792.08
 归属于母公司所有者的综合收益总额(元) 389,279,231.64237,091,995.48386,820,473.95371,304,455.67813,272,508.001,609,923,257.441,043,644,387.63
 归属于少数股东的综合收益总额(元) 7,517,881.519,896,263.03-16,592,156.67-5,317,387.288,204,620.4510,339,420.232,129,404.45
公告日期 2023-10-212023-08-302023-04-292023-02-212022-10-282022-07-292022-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院